Aldeyra Therapeutics

131 Hartwell Avenue
Lexington
Massachusetts
02421
United States

Tel: 781-761-4904

Email: dburke@theruthgroup.com

Show jobs for this employer

About Aldeyra Therapeutics


Aldeyra Therapeutics is a biotechnology company devoted to improving lives by inventing, developing and commercializing products that treat diseases thought to be related to endogenous aldehydes, a naturally occurring class of pro-inflammatory and toxic molecules. The company's lead product, NS2, is an aldehyde trap in development for ocular and systemic inflammation, as well as for Sjögren-Larsson Syndrome and Succinic Semi-Aldehyde Dehydrogenase Deficiency, two inborn errors of aldehyde metabolism.

YEAR FOUNDED:

2004

LEADERSHIP:

FOUNDERS: Thomas A. Jordan and John E. Dowling

CEO: Todd C. Brady

CMO: David J. Clark

CFO: Stephen Tulipano

JOB OPPORTUNITY:

Please click here for Aldeyra job opportunities..

CLINICAL TRIAL:

Please click here for clinical trial information..

134 articles with Aldeyra Therapeutics